MedPath

NOVA 7030 - LIQ

NOVA 7030 - LIQ

Discontinued
DIN Number

02121271

Drug Class

Human

Market Date

Feb 21, 1995

Company
HC

nova homeopathic therapeutics inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02121271
AIG Number0926597001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (9)

BELLADONNAActive
Strength: 6 X / ML
Monograph: BELLADONNA
CHAMOMILEActive
Strength: 4 X / ML
Monograph: CHAMOMILE
CITRULLUS COLOCYNTHISActive
Strength: 6 X / ML
Monograph: CITRULLUS COLOCYNTHIS
DIOSCOREA VILLOSAActive
Strength: 6 X / ML
Monograph: DIOSCOREA VILLOSA
LACTIC ACIDActive
Strength: 4 X / ML
Monograph: LACTIC ACID
MAGNESIUM PHOSPHATE DIBASICActive
Strength: 8 X / ML
Monograph: MAGNESIUM PHOSPHATE DIBASIC
MOMORDICA BALSAMINAActive
Strength: 4 X / ML
Monograph: MOMORDICA BALSAMINA
PLUMBUM METALLICUMActive
Strength: 8 X / ML
Monograph: PLUMBUM METALLICUM
TINActive
Strength: 8 X / ML
Monograph: TIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.